A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders

被引:199
作者
Besbas, N.
Karpman, D.
Landau, D.
Loirat, C.
Proesmans, W.
Remuzzi, G.
Rizzoni, G.
Taylor, C. M. [1 ]
Van de Kar, N.
Zimmerhackl, L. B.
机构
[1] Childrens Hosp, Dept Nephrol, Birmingham B4 6NH, W Midlands, England
[2] Hacettepe Univ, Ankara, Turkey
[3] Lund Univ, S-22100 Lund, Sweden
[4] Soroka Med Ctr, IL-84101 Beer Sheva, Israel
[5] Hop Robert Debre, F-75019 Paris, France
[6] Katholieke Univ Leuven Hosp, B-3000 Louvain, Belgium
[7] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy
[8] Bambino Gesu Pediat Hosp, Rome, Italy
[9] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands
[10] Univ Innsbruck, A-6020 Innsbruck, Austria
关键词
hemolytic uremic syndrome; thrombotic thrombocytopenic purpura; etiology;
D O I
10.1038/sj.ki.5001581
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The diagnostic terms hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP) are based on historical and overlapping clinical descriptions. Advances in understanding some of the causes of the syndrome now permit many patients to be classified according to etiology. The increased precision of a diagnosis based on causation is important for considering logical approaches to treatment and prognosis. It is also essential for research. We propose a classification that accommodates both a current understanding of causation (level 1) and clinical association in cases for whom cause of disease is unclear (level 2). We tested the classification in a pediatric disease registry of HUS. The revised classification is a stimulus to comprehensive investigation of all cases of HUS and TTP and is expected to increase the proportion of cases in whom a level 1 etiological diagnosis is confirmed.
引用
收藏
页码:423 / 431
页数:9
相关论文
共 142 条
  • [92] Hemolytic uremic syndrome in metastatic adenocarcinoma of the prostate
    Mungall, S
    Mathieson, P
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (06) : 1334 - 1336
  • [93] Nangaku M, 1998, J AM SOC NEPHROL, V9, P590
  • [94] Noris M, 1999, J AM SOC NEPHROL, V10, P281
  • [95] Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement
    Noris, M
    Bucchioni, S
    Galbusera, M
    Donadelli, R
    Bresin, E
    Castelletti, F
    Caprioli, J
    Brioschi, S
    Scheiflinger, F
    Remuzzi, G
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (05): : 1177 - 1183
  • [96] Familial haemolytic uraemic syndrome and an MCP mutation
    Noris, M
    Brioschi, S
    Caprioli, J
    Todeschini, M
    Bresin, E
    Porrati, F
    Gamba, S
    Remuzzi, G
    [J]. LANCET, 2003, 362 (9395) : 1542 - 1547
  • [97] Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure
    Ono, T
    Mimuro, J
    Madoiwa, S
    Soejima, K
    Kashiwakura, Y
    Ishiwata, A
    Takano, K
    Ohmori, T
    Sakata, Y
    [J]. BLOOD, 2006, 107 (02) : 528 - 534
  • [98] Cutting edge: Localization of the host recognition functions of complement factor H at the carboxyl-terminal: Implications for hemolytic uremic syndrome
    Pangburn, MK
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (09) : 4702 - 4706
  • [99] Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement
    Pangburn, MK
    [J]. IMMUNOPHARMACOLOGY, 2000, 49 (1-2): : 149 - 157
  • [100] Acute renal failure in the course of HIV infection: a single-institution retrospective study of ninety-two patients and sixty renal biopsies
    Peraldi, MN
    Maslo, C
    Akposso, K
    Mougenot, B
    Rondeau, E
    Sraer, JD
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (06) : 1578 - 1585